Status:
COMPLETED
World Trade Center (WTC) RENAL
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Collaborating Sponsors:
National Institute for Occupational Safety and Health (NIOSH/CDC)
Conditions:
Cardiac Disease
Cardiopulmonary Disease
Eligibility:
All Genders
40+ years
Brief Summary
Environmental toxins exert damaging health effects in workers. Thousands of responders who worked or volunteered on the World Trade Center (WTC) rescue and recovery effort following the September 11, ...
Detailed Description
Specific Aim 1. To quantify the risk of kidney damage and the relationship to particulate matter exposure among first responders to the WTC attack. Urine samples will be collected on 2 occasions for ...
Eligibility Criteria
Inclusion
- WTC responders who were enrolled in the WTC-CHEST program.
- World Trade Center responders who are currently enrolled in the World Trade Center Health Program-Clinical Center of Excellence, formerly known as the WTC Medical Monitoring and Treatment Program
- Over the age of 39 years
Exclusion
- \-
Key Trial Info
Start Date :
July 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 16 2016
Estimated Enrollment :
406 Patients enrolled
Trial Details
Trial ID
NCT02246101
Start Date
July 1 2014
End Date
September 16 2016
Last Update
July 26 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Icahn School of Medicine at Mount Sinai
New York, New York, United States, 10029